Published in Vaccine Weekly, April 21st, 1997
The work had previously been funded by the U.S. Army Medical Research and Development Command under an SBIR contract to further develop the technology for the delivery of hepatitis A vaccine.
According to the World Health Organization (WHO), the 1995 global vaccine market was estimated at $3 billion. A major issue with current vaccine technology continues to be the need for vaccines that deliver all of the required components in a single administration rather than a format that requires...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.